Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PFE
PFE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PFE News
Dividend Investment Opportunities in Pfizer and Bristol Myers Squibb
13h ago
Fool
Pfizer's Dividend Risks Heighten Amid Challenges
20h ago
Fool
High Dividend Stock Analysis: Verizon Leads
1d ago
Fool
Pfizer Eyes Kailera Acquisition to Expand Weight Loss Portfolio
5d ago
Fool
Alnylam Pharmaceuticals Shares Drop 24%, Yet Optimism Persists
6d ago
Fool
Alnylam Pharmaceuticals Reports Strong Q1 Performance
6d ago
NASDAQ.COM
Two Stocks Wall Street Loves and One to Sell
6d ago
Yahoo Finance
Comparing Dividends: Pfizer vs. Verizon
6d ago
Fool
Dividend Comparison: Pfizer vs. Verizon
6d ago
NASDAQ.COM
Nike Reports Mixed Q4 Results, Stock Declines
Jun 30 2026
Yahoo Finance
US House Committee Investigates Pharma Trials at Chinese Military Sites
Jun 30 2026
seekingalpha
US Terminates Emergency Authorizations for COVID-19 Treatments
Jun 30 2026
seekingalpha
Nike Faces Sales Decline Ahead of Earnings Report
Jun 30 2026
CNBC
Pfizer Acquires Metsera to Enter Obesity Drug Market
Jun 30 2026
Fool
Pfizer's Metsera Acquisition Opens Opportunities in Obesity Market
Jun 30 2026
NASDAQ.COM
Nike Expected to Report Eighth Straight Quarter of Declining Profits
Jun 30 2026
NASDAQ.COM
Show More News
